LAUSR

Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial

Sign Up to like & get
recommendations!
0 Published in 2018 at "Clinical Oral Investigations"

DOI: 10.1007/s00784-018-2519-6

Abstract: ObjectivesOral lichen plans (OLP) is a potentially malignant inflammatory mucocutaneous disease. CD133 is an investigated surface marker for cancer stem-like cells (CSCs) that may be involved in tumor initiation in head and neck carcinomas. We… read more here.

Keywords: topical pimecrolimus; lichen; treatment; pimecrolimus ... See more keywords